Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Plotinus's Profile
Displaying 251-300 of 630 result(s).
CYDY CytoDyn Inc
10/26/2023 7:03:58 PM
Doubtful Welch gets a boilerplate r (5)
CYDY CytoDyn Inc
10/25/2023 4:58:58 PM
Adding this relevant link as Enjay (4)
CYDY CytoDyn Inc
10/25/2023 4:49:27 PM
This study published in Cell a litt (2)
CYDY CytoDyn Inc
10/20/2023 1:58:31 PM
Preach…truer words never spoken o
CYDY CytoDyn Inc
10/19/2023 8:34:53 AM
I did get a response from IR, I am (8)
CYDY CytoDyn Inc
10/18/2023 5:22:55 PM
I took up earlier suggestions and w (13)
CYDY CytoDyn Inc
10/18/2023 1:17:34 PM
The company has previously stated t (6)
CYDY CytoDyn Inc
10/18/2023 11:44:14 AM
I agree, to borrow from your sugges (1)
CYDY CytoDyn Inc
10/16/2023 2:51:37 PM
“Yet they delay us by asking for (5)
CYDY CytoDyn Inc
10/01/2023 12:25:49 PM
Quite an elegant bit of research to (3)
CYDY CytoDyn Inc
09/25/2023 4:02:44 PM
Sums up my Jekyll and Hyde response (2)
CYDY CytoDyn Inc
09/25/2023 11:47:41 AM
Their is no paucity of indications (7)
CYDY CytoDyn Inc
09/25/2023 11:40:21 AM
Ball spike at 17.7 sure triggered a (1)
CYDY CytoDyn Inc
09/21/2023 10:44:44 AM
It might have to do with degree of
CYDY CytoDyn Inc
09/17/2023 3:40:33 PM
David Welch has hung on, unwavering (3)
CYDY CytoDyn Inc
09/16/2023 3:53:22 PM
War-chest and hat noted; Respert an (3)
CYDY CytoDyn Inc
09/16/2023 11:44:30 AM
“Even if the agreement to buy or (4)
CYDY CytoDyn Inc
09/16/2023 9:24:09 AM
Everything depends on how the share (8)
CYDY CytoDyn Inc
09/12/2023 2:23:27 PM
The FDA has been treated with QUICK (3)
CYDY CytoDyn Inc
09/12/2023 9:12:16 AM
Not sure if this highly thorough re (21)
CYDY CytoDyn Inc
09/05/2023 1:13:47 PM
I don’t necessarily disagree with (2)
CYDY CytoDyn Inc
09/05/2023 11:52:56 AM
You could also argue HIV monotherap (7)
CYDY CytoDyn Inc
09/04/2023 3:29:17 PM
Keep in mind those bulls-eye target (3)
CYDY CytoDyn Inc
09/04/2023 1:08:54 PM
Comparable long position and sentim (10)
CYDY CytoDyn Inc
08/25/2023 2:16:41 PM
True value always wins out in the e (1)
CYDY CytoDyn Inc
08/25/2023 2:12:23 PM
Not my area of expertise but the la (7)
CYDY CytoDyn Inc
08/24/2023 10:19:41 PM
Prop up vs replace…a thoughtful u (10)
CYDY CytoDyn Inc
08/23/2023 12:27:52 PM
Either HAL 9000 has been replaced o (4)
CYDY CytoDyn Inc
08/12/2023 12:35:57 PM
The HIV data is technically is usea (8)
CYDY CytoDyn Inc
08/11/2023 3:14:48 PM
I would say we have some very posit (3)
CYDY CytoDyn Inc
08/04/2023 5:02:39 PM
Au contraire, you’ve hinted at th (3)
CYDY CytoDyn Inc
08/03/2023 11:34:29 AM
Thanks for the hyperlink and your c (10)
CYDY CytoDyn Inc
08/03/2023 8:11:30 AM
Thanks for the link to the pre-clin (1)
CYDY CytoDyn Inc
08/02/2023 8:58:07 PM
Appreciate the smoke signal we appe (4)
CYDY CytoDyn Inc
08/01/2023 6:35:52 PM
“the sky will begin to clear for (5)
CYDY CytoDyn Inc
08/01/2023 2:53:37 PM
Why you can’t wait forever to mov (8)
CYDY CytoDyn Inc
08/01/2023 2:24:03 PM
Yesterday’s volume was a little o (2)
CYDY CytoDyn Inc
08/01/2023 11:08:51 AM
The irony of a safety hold on Leron (10)
CYDY CytoDyn Inc
07/31/2023 10:54:48 PM
BP is motivated pre-eminently by mo (4)
CYDY CytoDyn Inc
07/31/2023 10:40:27 PM
Speaking of too many iron’s in th (1)
CYDY CytoDyn Inc
07/31/2023 10:53:37 AM
“Until then they’re laughing al (3)
CYDY CytoDyn Inc
07/28/2023 3:54:36 PM
Thanks…still speculative…glad s (1)
CYDY CytoDyn Inc
07/28/2023 2:30:06 PM
As I have followed the boards on th (1)
CYDY CytoDyn Inc
07/28/2023 1:16:24 PM
To the barricades here also…don†(2)
CYDY CytoDyn Inc
07/27/2023 10:40:35 PM
In the link below there is speculat (1)
CYDY CytoDyn Inc
07/27/2023 4:48:16 PM
Agree the share price is cheap but (9)
CYDY CytoDyn Inc
07/26/2023 5:00:41 PM
Not to answer your question directl (5)
CYDY CytoDyn Inc
07/26/2023 12:38:20 PM
This appears to imply adequate: “ (5)
CYDY CytoDyn Inc
07/26/2023 11:54:25 AM
When Jonah Sacha is done with his w (9)
CYDY CytoDyn Inc
07/25/2023 5:22:28 PM
I think you should consider changin (4)
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Stock Stars of the Week: Insights into Recent Gains
  • Take Action If You've Lost Over $100K in 3D Systems
  • Updates on Class Action Suit Against Novo Nordisk Investors
  • Bitcoin Swift's Stage 3 Presale: Unprecedented Yield Opportunities
  • Join the Class Action Against PepGen Securities Fraud Now
  • Sarepta Investors Encouraged to Join Legal Action for Justice
  • Hangzhou Strengthens Global Connections Through Cultural Ties
  • Investors Encouraged to Join Rocket Pharmaceuticals Class Action
  • Market Insights: Declining Large Caps and Financial Impacts
  • Opportunity for Investors Affected by Petco Securities Fraud
  • Investors Can Lead 3D Systems Securities Fraud Class Action
  • Investors Urged to Join Alto Neuroscience Securities Lawsuit
  • Investors Urged to Join Lawsuit Against Vestis Corporation Today
  • Important Legal Updates for PepGen Inc. Investors Ahead
  • Investors Have a Unique Chance to Lead Fiserv's Securities Case
  • Investors Encouraged to Join the Centene Securities Fraud Case
  • HashJ Unveils User-Friendly XRP Contracts Amid Market Surge
  • Tech Giants' Earnings Insight Amid Economic Concerns
  • Investors Can Lead Legal Action Against Hims Securities Fraud
  • Investors Can Take Action in the iRobot Class Action Suit
  • J.M. Smucker Co. Under Scrutiny: Investment Concerns Arise
  • Hims & Hers Legal Situation: Understanding Your Options
  • Sarepta Therapeutics Faces Legal Challenges Over Elevidys Risks
  • Legal Considerations for RxSight, Inc. Investors Amidst Stock Decline
  • Michael Owen Partners with GK8 for iGaming Expansion Success
  • HashJ Expands Accessibility for XRP Investors with New Contracts
  • Trice Contracting Inc. Expands Services for Historic Preservation
  • Revolutionary Weight Loss Pill Offers New Hope for Obesity
  • Exploring the Future of Internet Connectivity with Starlink
  • Seize the Moment: Participate in Reckitt Benckiser Class Action
  • Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Impact of Tariff Loophole Elimination on Global Commerce
  • Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
  • Unveiling Success: President Trump's Achievements This Week
  • Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
  • Elon Musk Addresses Control Concerns Amid Shareholder Influence
  • Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
  • President Trump’s Vision: Turning America’s Aspirations into Reality
  • Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
  • Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
  • Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune
  • TrimIQ UK Launch: A Revolutionary Approach to Wellness
  • Exploring Arialief: A Natural Solution for Nerve Pain Relief
  • Unlocking the Secrets of No Deposit Free Spins at Wild Casino
  • Sam Altman's Urgent Caution on AI Risks and Innovations
  • Matsato Knife Revolutionizes Culinary Tools in Key Markets
  • Discover the Benefits of Audizen Drops for Nerve Health
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site